Skip to main content
Erschienen in: Journal of Neurology 2/2007

01.02.2007 | ORIGINAL COMMUNICATION

Quantitative measurement of trunk rigidity in parkinsonian patients

verfasst von: Margaret K.Y. Mak, Eric C.Y. Wong, Christina W.Y. Hui-Chan, PhD

Erschienen in: Journal of Neurology | Ausgabe 2/2007

Einloggen, um Zugang zu erhalten

Abstract

We aimed to develop an objective measurement to quantify trunk rigidity in patients with Parkinson’s disease (PD), and to examine its reliability, validity and sensitivity in differentiating PD patients from control subjects. In Study 1, an isokinetic dynamometer was employed to assess trunk rigidity in 6 PD patients and 6 healthy controls. Passive trunk flexion and extension at 4 angular velocities were applied and resistive torques were recorded. Both work done and resistive peak torques to passive trunk flexion (TorquePF) and extension (TorquePE) were found to be highly reliable within a 2-day interval in PD patients and control subjects. In Study 2, trunk muscle tone was compared between 15 PD and 15 control subjects. Significantly higher muscle tone, as shown by increases in work done, and in TorquePF and TorquePE at higher movement speeds, was found in PD patients. Within each subject group, resistive trunk muscle tone was found to increase with increasing velocity of passive movement, but the extent of increase was greater in PD patients. Our results thus suggest that the objective method developed by us was reliable and could differentiate trunk rigidity in PD patients from that of healthy subjects.
Literatur
1.
Zurück zum Zitat Mutch WJ, Strudwick A, Roy SK, Downie AW (1986) Parkinson’s disease: disability, review, and management. BMJ 293:675–677PubMedCrossRef Mutch WJ, Strudwick A, Roy SK, Downie AW (1986) Parkinson’s disease: disability, review, and management. BMJ 293:675–677PubMedCrossRef
2.
Zurück zum Zitat Berardelli A, Sabra AF, Hallett M (1983) Physiological mechanisms of rigidity in Parkinson’s disease. J Neurol Neurosurg Psychiatry 46:45–53PubMed Berardelli A, Sabra AF, Hallett M (1983) Physiological mechanisms of rigidity in Parkinson’s disease. J Neurol Neurosurg Psychiatry 46:45–53PubMed
3.
Zurück zum Zitat Delwaide JP (2001) Parkinsonian Rigidity. Funct Neurol 16:147–156PubMed Delwaide JP (2001) Parkinsonian Rigidity. Funct Neurol 16:147–156PubMed
4.
Zurück zum Zitat Teräväinen H, Tsuim JKC, Mak E, Calne DB (1989) Optimal indices for testing parkinsonian rigidity. Can J Neurol Sci 16:180–3PubMed Teräväinen H, Tsuim JKC, Mak E, Calne DB (1989) Optimal indices for testing parkinsonian rigidity. Can J Neurol Sci 16:180–3PubMed
5.
Zurück zum Zitat Fung VSC, Burne JA, Morris JGL (2000) Objective quantification of resting and activated parkinsonian rigidity: a comparison of angular impulse and work scores. Mov Disord 15:48–55PubMedCrossRef Fung VSC, Burne JA, Morris JGL (2000) Objective quantification of resting and activated parkinsonian rigidity: a comparison of angular impulse and work scores. Mov Disord 15:48–55PubMedCrossRef
6.
Zurück zum Zitat Lee HM, Huang YZ, Chen JJJ, Hwang IS (2002) Quantitative analysis of the velocity related pathophysiology of spasticity and rigidity in the elbow flexors. J Neurol Neurosurg Psychiatry 72:621–629PubMedCrossRef Lee HM, Huang YZ, Chen JJJ, Hwang IS (2002) Quantitative analysis of the velocity related pathophysiology of spasticity and rigidity in the elbow flexors. J Neurol Neurosurg Psychiatry 72:621–629PubMedCrossRef
7.
Zurück zum Zitat Nuyens G, De Weerdt W, Dom R, Nieuwboer A, Spaepen A (2000) Torque variations during repeated passive isokinetic movements of the knee in subjects with Parkinson’s disease and healthy control subjects. Parkinsonism Relat Disord 6:87–93PubMedCrossRef Nuyens G, De Weerdt W, Dom R, Nieuwboer A, Spaepen A (2000) Torque variations during repeated passive isokinetic movements of the knee in subjects with Parkinson’s disease and healthy control subjects. Parkinsonism Relat Disord 6:87–93PubMedCrossRef
8.
Zurück zum Zitat Caligiuri MP (1994) Portable device for quantifying parkinsonian wrist rigidity. Mov Disord 9:57–63PubMedCrossRef Caligiuri MP (1994) Portable device for quantifying parkinsonian wrist rigidity. Mov Disord 9:57–63PubMedCrossRef
9.
Zurück zum Zitat Tanigawa A, Komiyama A, Hasegawa O (1998) Truncal muscle tonus in progressive supranuclear palsy. J Neurol, Neurosurg Psychiatry 64:190–196 Tanigawa A, Komiyama A, Hasegawa O (1998) Truncal muscle tonus in progressive supranuclear palsy. J Neurol, Neurosurg Psychiatry 64:190–196
10.
Zurück zum Zitat Bejjani BP, Gervais D, Arnulf I, Papadopoulos S, Demeret, Bonnet AM, Cornu P, Damier P, Agid Y (2000) Axial parkinsonism symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation. J Neurol, Neurosurg Psychiatry 68:595–600 Bejjani BP, Gervais D, Arnulf I, Papadopoulos S, Demeret, Bonnet AM, Cornu P, Damier P, Agid Y (2000) Axial parkinsonism symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation. J Neurol, Neurosurg Psychiatry 68:595–600
11.
Zurück zum Zitat Steiger AJ, Thompson PD, Marsden CD (1996) Disordered axial movement in Parkinson’s disease. J Neurol, Neurosurg Psychiatry 61:645–648 Steiger AJ, Thompson PD, Marsden CD (1996) Disordered axial movement in Parkinson’s disease. J Neurol, Neurosurg Psychiatry 61:645–648
12.
Zurück zum Zitat Van Emmerik REA, Wagenaar RC, Wingrodzka A, Wolters EC (1999) Identification of axial rigidity during locomotion in Parkinson’s disease. Arch Phys Med Rehabil 80:186–191PubMedCrossRef Van Emmerik REA, Wagenaar RC, Wingrodzka A, Wolters EC (1999) Identification of axial rigidity during locomotion in Parkinson’s disease. Arch Phys Med Rehabil 80:186–191PubMedCrossRef
13.
Zurück zum Zitat Fahn S, Elton RL. Members of the UPDRS development committee (1987) Unified Parkinson’s disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, (eds) Recent developments in Parkinson’s disease, Vol 2. Macmillan, Florham Park, NJ, pp 153–163, 293–304 Fahn S, Elton RL. Members of the UPDRS development committee (1987) Unified Parkinson’s disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, (eds) Recent developments in Parkinson’s disease, Vol 2. Macmillan, Florham Park, NJ, pp 153–163, 293–304
14.
Zurück zum Zitat Quinn N (1995) Parkinsonism: recognition and differential diagnosis. BMJ 310:447–452PubMed Quinn N (1995) Parkinsonism: recognition and differential diagnosis. BMJ 310:447–452PubMed
15.
Zurück zum Zitat Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442PubMedCrossRef Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442PubMedCrossRef
16.
Zurück zum Zitat Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state.” A practical method for grading the cognitive state of patients for clinician. J Psychiatr Res 12:189–198PubMedCrossRef Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state.” A practical method for grading the cognitive state of patients for clinician. J Psychiatr Res 12:189–198PubMedCrossRef
17.
Zurück zum Zitat Cybex Norm testing & rehabilitation system (1995–96): User’s guide. Cybex International, New York Cybex Norm testing & rehabilitation system (1995–96): User’s guide. Cybex International, New York
18.
Zurück zum Zitat Duncan PW, Weiner D, Chandler J, Studenski S (1990). Functional reach: a new clinical measure of balance. J Gerontol 45:M192–197PubMed Duncan PW, Weiner D, Chandler J, Studenski S (1990). Functional reach: a new clinical measure of balance. J Gerontol 45:M192–197PubMed
19.
Zurück zum Zitat Smithson F, Morris ME, Iansek R (1998). Performance on clinical test of balance in Parkinson’s disease. Phys Ther 78:577–92PubMed Smithson F, Morris ME, Iansek R (1998). Performance on clinical test of balance in Parkinson’s disease. Phys Ther 78:577–92PubMed
20.
Zurück zum Zitat Nicholas DP (1998) Choosing an Intraclass Correlation Coefficient. SPSS keywords pp 67 Nicholas DP (1998) Choosing an Intraclass Correlation Coefficient. SPSS keywords pp 67
21.
Zurück zum Zitat Fleiss JL (1986) The design and analysis of clinical experiments. John Wiley & Sons, New York Fleiss JL (1986) The design and analysis of clinical experiments. John Wiley & Sons, New York
22.
Zurück zum Zitat Portney LG (2000) Foundations of clinical research: applications to practice 2nd ed. Prentice Hall Health, New Jersey Portney LG (2000) Foundations of clinical research: applications to practice 2nd ed. Prentice Hall Health, New Jersey
23.
Zurück zum Zitat Lee RG (1989) Pathophysiology of rigidity and akinesia in Parkinson’s disease. Eur Neurol 29(Suppl 1):13–18PubMed Lee RG (1989) Pathophysiology of rigidity and akinesia in Parkinson’s disease. Eur Neurol 29(Suppl 1):13–18PubMed
24.
Zurück zum Zitat Bergui M, Lapiano L, Paglia G, Quattrocolo G, Scarzella L, Bergamasco B (1992) Stretch reflex of quadriceps femoris and its relation to rigidity in Parkinson’s disease. Acta Neurol Scand 86:226–229PubMedCrossRef Bergui M, Lapiano L, Paglia G, Quattrocolo G, Scarzella L, Bergamasco B (1992) Stretch reflex of quadriceps femoris and its relation to rigidity in Parkinson’s disease. Acta Neurol Scand 86:226–229PubMedCrossRef
25.
Zurück zum Zitat Chan CWY, Kearney RE, Jones GM (1979) Tibialis anterior response to sudden ankle displacements in normal and parkinsonian subjects. Brain Res 173:303–314PubMedCrossRef Chan CWY, Kearney RE, Jones GM (1979) Tibialis anterior response to sudden ankle displacements in normal and parkinsonian subjects. Brain Res 173:303–314PubMedCrossRef
26.
Zurück zum Zitat Dietz V, Quintern J, Berger W (1981) Electrophysiological studies of gait in spasticity and rigidity. Evidence that altered mechanical properties of muscle contribute to hypertonia. Brain 104:431–449PubMedCrossRef Dietz V, Quintern J, Berger W (1981) Electrophysiological studies of gait in spasticity and rigidity. Evidence that altered mechanical properties of muscle contribute to hypertonia. Brain 104:431–449PubMedCrossRef
27.
Zurück zum Zitat Edstrom L (1970) Selective changes in the sizes of red and white muscle fibres in upper motor lesions and parkinsonism. J Neurol Sci 11:537–550PubMedCrossRef Edstrom L (1970) Selective changes in the sizes of red and white muscle fibres in upper motor lesions and parkinsonism. J Neurol Sci 11:537–550PubMedCrossRef
28.
Zurück zum Zitat Rothwell JC, Obeso JA, Traub MM, Marsden CD (1983) The behaviour of the long-latency stretch reflex in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 46:35–44PubMed Rothwell JC, Obeso JA, Traub MM, Marsden CD (1983) The behaviour of the long-latency stretch reflex in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 46:35–44PubMed
29.
Zurück zum Zitat Lee RG, Tatton WG (1975) Motor responses to sudden limb displacement in primates with specific CNS lesions and in human patients with motor system disorders. Can J Neurol Sci 2:285–293PubMed Lee RG, Tatton WG (1975) Motor responses to sudden limb displacement in primates with specific CNS lesions and in human patients with motor system disorders. Can J Neurol Sci 2:285–293PubMed
30.
Zurück zum Zitat Meara RJ, Cody FWJ (1993) Stretch reflexes of individual parkinsonian patients studied during changes in clinical rigidity following medication. Clin Neurophysiol 89:261–268 Meara RJ, Cody FWJ (1993) Stretch reflexes of individual parkinsonian patients studied during changes in clinical rigidity following medication. Clin Neurophysiol 89:261–268
31.
Zurück zum Zitat Prochazka A, Bennett DJ, Stephens MJ, Patrick SK, Sears-Duru R, Roberts T, Jhamandas JH (1997). Measurement of rigidity in Parkinson’s disease. Mov Disord 12:24–32PubMedCrossRef Prochazka A, Bennett DJ, Stephens MJ, Patrick SK, Sears-Duru R, Roberts T, Jhamandas JH (1997). Measurement of rigidity in Parkinson’s disease. Mov Disord 12:24–32PubMedCrossRef
32.
Zurück zum Zitat Ransmayr G, Kunig G, Neubauer M, Wagner M, Falk M (1995) Effect of age and disease duration on parkinsonian motor scores under levodopa therapy. J Neural Trans 9:177–188CrossRef Ransmayr G, Kunig G, Neubauer M, Wagner M, Falk M (1995) Effect of age and disease duration on parkinsonian motor scores under levodopa therapy. J Neural Trans 9:177–188CrossRef
33.
Zurück zum Zitat Fama R, Sullivan EV (2002) Motor sequencing in Parkinson’s disease: relationship to executive function and motor rigidity. Cortex 38:753–767PubMed Fama R, Sullivan EV (2002) Motor sequencing in Parkinson’s disease: relationship to executive function and motor rigidity. Cortex 38:753–767PubMed
34.
Zurück zum Zitat Diederich NJ, Moore CG, Leurgans SE, Chmura TA, Goetz CG (2003) Parkinson’s disease with old-age onset: a comparative study with subjects with middle-age onset. Arch Neurol 60:529–533PubMedCrossRef Diederich NJ, Moore CG, Leurgans SE, Chmura TA, Goetz CG (2003) Parkinson’s disease with old-age onset: a comparative study with subjects with middle-age onset. Arch Neurol 60:529–533PubMedCrossRef
35.
Zurück zum Zitat Bloem BR, Beckley DJ, Van Dijk JG (1999) Are automatic postural responses in patients with Parkinson’s disease abnormal due to their stooped posture? Exp Brain Res 124:481–488PubMedCrossRef Bloem BR, Beckley DJ, Van Dijk JG (1999) Are automatic postural responses in patients with Parkinson’s disease abnormal due to their stooped posture? Exp Brain Res 124:481–488PubMedCrossRef
Metadaten
Titel
Quantitative measurement of trunk rigidity in parkinsonian patients
verfasst von
Margaret K.Y. Mak
Eric C.Y. Wong
Christina W.Y. Hui-Chan, PhD
Publikationsdatum
01.02.2007
Erschienen in
Journal of Neurology / Ausgabe 2/2007
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-006-0327-4

Weitere Artikel der Ausgabe 2/2007

Journal of Neurology 2/2007 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.